Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aria Darou (Aria Darou Paya) is a private pharmaceutical company headquartered in Tehran, Iran, specializing in the development and production of finished dosage forms. Established in 2002, the company focuses on key therapeutic areas including oncology, endocrinology, cardiovascular health, and central nervous system disorders. Aria Darou operates manufacturing facilities that adhere to international Good Manufacturing Practice (GMP) standards, producing a diverse range of oral solids such as tablets and capsules. The company plays a significant role in the domestic Iranian healthcare market by providing high-quality generic medications and specialized hormonal treatments. Through its commitment to research and quality, Aria Darou aims to expand its reach into regional export markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aria Darou.